We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...
Accordingly, we propose a supertwisting sliding mode and iterative learning-based synchronization control (STILSC) for 2R1T parallel robot to achieve high tracking accuracy. The using of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback